Dr. David N. Potier

Dr. David Potier


2004-2008 MChem (Hons)
University of Manchester
Manchester, UK
2008-2012 PhD
University of Manchester
Manchester, UK


Present Appointment

2013- Biochemist, Protein Analysis Team
SGS M-Scan, Wokingham, Berkshire, UK


Previous Appointment

2012-2013 Research Associate
Cardiovascular Division, King’s College London, London, UK
2006-2007 Analytical Scientist, Early Inhaled Development Department
GlaxoSmithKline, Ware, Hertfordshire, UK



1 Barallobre-Barreiro J, Oklu R, Lynch M, Fava M, Baig F, Yin X, Barwari T, Potier D, Albadawi H, Jahangiri M, Porter K, Watkins M, Misra S, Stoughton J, Mayr M. Extracellular Matrix Remodeling in Response to Venous Hypertension: Proteomics of Human Varicose Veins. Cardiovasc Res. 2016 110 : 419-430. [Full Text] [PubMed] [DOI]

2 Potier DN, Griffiths JR, Unwin RD, Walker MJ, Carrick E, Willamson AJ, Whetton AD. An assessment of peptide enrichment methods employing mTRAQ quantification approaches. Anal Chem. 2012 84 : 5604-5610. [PubMed] [DOI]

3 Griaud F, Williamson AJ, Taylor S, Potier DN, Spooncer E, Pierce A, Whetton AD. BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response. J Proteomics. 2012 77 : 14-26. [PubMed] [DOI]

PHP Code Snippets Powered By : XYZScripts.com